NCT07526831 Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee Surgery
| NCT ID | NCT07526831 |
| Status | Recruiting |
| Phase | — |
| Sponsor | TC Erciyes University |
| Condition | Knee Arthroplasty, Total |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2028-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2026-04-15 with a primary completion date of 2028-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the effectiveness of Adductor Canal Block and combined Adductor Canal plus IPACK block in reducing postoperative pain and analgesic requirements in patients undergoing knee surgery.
Eligibility Criteria
Inclusion Criteria: * ASA (American Society of Anesthesiologists) I- ASA II-ASA III Patients Exclusion Criteria: * history of allergy to the study medication * refusal to participate
Contact & Investigator
Sibel Pehlivan
STUDY DIRECTOR
Erciyes Üniversitesi
Frequently Asked Questions
Who can join the NCT07526831 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Arthroplasty, Total. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07526831 currently recruiting?
Yes, NCT07526831 is actively recruiting participants. Contact the research team at Sibelpehlivan@erciyes.edu.tr for enrollment information.
Where is the NCT07526831 trial being conducted?
This trial is being conducted at Kayseri, Turkey (Türkiye), Kayseri, Turkey (Türkiye).
Who is sponsoring the NCT07526831 clinical trial?
NCT07526831 is sponsored by TC Erciyes University. The principal investigator is Sibel Pehlivan at Erciyes Üniversitesi. The trial plans to enroll 60 participants.